NO178065C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive nye vitamin D-analoger, samt mellomprodukt - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive nye vitamin D-analoger, samt mellomprodukt

Info

Publication number
NO178065C
NO178065C NO912902A NO912902A NO178065C NO 178065 C NO178065 C NO 178065C NO 912902 A NO912902 A NO 912902A NO 912902 A NO912902 A NO 912902A NO 178065 C NO178065 C NO 178065C
Authority
NO
Norway
Prior art keywords
formula
well
compounds
analogues
therapeutically active
Prior art date
Application number
NO912902A
Other languages
English (en)
Norwegian (no)
Other versions
NO178065B (no
NO912902L (no
NO912902D0 (no
Inventor
Martin John Calverley
Kai Hansen
Lise Binderup
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of NO912902L publication Critical patent/NO912902L/no
Publication of NO912902D0 publication Critical patent/NO912902D0/no
Publication of NO178065B publication Critical patent/NO178065B/no
Publication of NO178065C publication Critical patent/NO178065C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO912902A 1989-02-23 1991-07-25 Analogifremgangsmåte ved fremstilling av terapeutisk aktive nye vitamin D-analoger, samt mellomprodukt NO178065C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898904154A GB8904154D0 (en) 1989-02-23 1989-02-23 Chemical compounds
PCT/DK1990/000036 WO1990009991A1 (en) 1989-02-23 1990-02-13 Novel vitamin d analogues
SG131794A SG131794G (en) 1989-02-23 1994-09-12 Novel vitamin D analogues

Publications (4)

Publication Number Publication Date
NO912902L NO912902L (no) 1991-07-25
NO912902D0 NO912902D0 (no) 1991-07-25
NO178065B NO178065B (no) 1995-10-09
NO178065C true NO178065C (no) 1996-01-17

Family

ID=26295003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912902A NO178065C (no) 1989-02-23 1991-07-25 Analogifremgangsmåte ved fremstilling av terapeutisk aktive nye vitamin D-analoger, samt mellomprodukt

Country Status (22)

Country Link
EP (1) EP0460032B1 (pt)
JP (1) JP2807083B2 (pt)
KR (1) KR0163194B1 (pt)
AT (1) ATE104957T1 (pt)
AU (1) AU627001B2 (pt)
CA (1) CA2044280C (pt)
DE (1) DE69008517T2 (pt)
DK (1) DK0460032T3 (pt)
ES (1) ES2055905T3 (pt)
FI (1) FI92929C (pt)
GB (1) GB8904154D0 (pt)
HK (1) HK128894A (pt)
HU (1) HU211025B (pt)
IE (1) IE63123B1 (pt)
LT (1) LT3983B (pt)
LV (1) LV10428B (pt)
NO (1) NO178065C (pt)
PT (1) PT93232B (pt)
RO (1) RO109939B1 (pt)
RU (1) RU2037484C1 (pt)
SG (1) SG131794G (pt)
WO (1) WO1990009991A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
GB9015774D0 (en) * 1990-07-18 1990-09-05 Leo Pharm Prod Ltd Novel treatment
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) * 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6316642B1 (en) 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6306844B1 (en) 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US5939406A (en) 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US6359152B2 (en) 1997-07-21 2002-03-19 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
JP4046363B2 (ja) * 1998-03-04 2008-02-13 帝人株式会社 活性型ビタミンd3乳剤性ローション剤
US5962707A (en) * 1998-08-18 1999-10-05 Wisconsin Alumni Research Foundation 19-nor-vitamin D3 compounds with calcemic activity
PT3146969T (pt) * 1999-04-23 2018-10-18 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
EP1275643A4 (en) * 2000-04-19 2009-06-03 Chugai Pharmaceutical Co Ltd VITAMIN D DERIVATIVES
US20030018017A1 (en) * 2001-01-25 2003-01-23 Deluca Hector F. Method of treatment of type I diabetes
WO2004076468A1 (ja) * 2003-02-25 2004-09-10 Kobe Tennenbutsu Kagaku Kabushiki Kaisha ビタミンd誘導体を合成するための新規な中間体
BRPI0409194A (pt) 2003-04-10 2006-04-11 Wisconsin Alumni Res Found compostos, composição farmacêutica e método de tratamento de doença metabólica do osso, da psorìase, da leucemia, cáncer do cólon, cáncer da mama, cáncer da pele ou cáncer da próstata, de doença auto-imune, de doença inflamatória do intestino e de aumento da resistência do osso
US6894037B2 (en) 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
US7713951B2 (en) 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
EP2010483A2 (en) 2006-04-05 2009-01-07 Wisconsin Alumni Research Foundation 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
JP5563324B2 (ja) * 2010-02-03 2014-07-30 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトール中間体およびその製造方法
JP2014514274A (ja) 2011-03-09 2014-06-19 テバ ファーマシューティカル インダストリーズ リミティド マキサカルシトールの多形およびマキサカルシトールの調製方法
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
CN103910666A (zh) * 2014-04-15 2014-07-09 湖南华腾制药有限公司 一种制备马沙骨化醇的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078704B1 (en) 1981-11-02 1987-04-29 Research Institute For Medicine And Chemistry Inc. Intermediates in the synthesis of vitamin d derivatives
DE3577552D1 (de) * 1984-11-27 1990-06-13 Chugai Pharmaceutical Co Ltd Vitamin d-derivate und verfahren zu deren herstellung.
JPH07100685B2 (ja) 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ/エス(レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ) 新規ビタミンd類似体
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
FI92929B (fi) 1994-10-14
HUT59664A (en) 1992-06-29
HU211025B (en) 1995-09-28
KR920701145A (ko) 1992-08-11
CA2044280C (en) 1999-12-21
DK0460032T3 (da) 1994-06-06
GB8904154D0 (en) 1989-04-05
LTIP1536A (en) 1995-09-25
KR0163194B1 (ko) 1999-01-15
IE900421L (en) 1990-08-23
AU627001B2 (en) 1992-08-13
WO1990009991A1 (en) 1990-09-07
PT93232A (pt) 1990-08-31
DE69008517T2 (de) 1994-08-18
SG131794G (en) 1995-01-13
NO178065B (no) 1995-10-09
AU5198390A (en) 1990-09-26
DE69008517D1 (de) 1994-06-01
JP2807083B2 (ja) 1998-09-30
RO109939B1 (ro) 1995-07-28
NO912902L (no) 1991-07-25
LV10428A (lv) 1995-02-20
NO912902D0 (no) 1991-07-25
FI92929C (fi) 1995-01-25
IE63123B1 (en) 1995-03-22
HK128894A (en) 1994-11-25
JPH04503669A (ja) 1992-07-02
RU2037484C1 (ru) 1995-06-19
LV10428B (en) 1995-10-20
PT93232B (pt) 1995-12-29
CA2044280A1 (en) 1990-08-24
ES2055905T3 (es) 1994-09-01
EP0460032A1 (en) 1991-12-11
FI913812A0 (fi) 1991-08-12
LT3983B (en) 1996-06-25
ATE104957T1 (de) 1994-05-15
EP0460032B1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
NO178065C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive nye vitamin D-analoger, samt mellomprodukt
FI916151A0 (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
CA2078555A1 (en) Novel vitamin d analogues
DK0460034T3 (da) Nye D-vitaminanaloger
HUT42095A (en) Process for producing purine ring or analogue ring-systhems /heteropurine/-containing compounds and pharmaceutical compositions containing them
IE782070L (en) Azabicyclo (3.2.0) hept-2-ene carboxylic acid derivatives
ES474289A1 (es) Un procedimiento para la preparacion de derivados del acido 6-(1'-hidroxietil)-7-oxi-1-aza-biciclo(3,2,0)hept-2-en -2- carboxilico-3-sustutuidos
NZ234216A (en) Vitamin d analogues, preparation and pharmaceutical compositions thereof
RU95113157A (ru) Новые аналоги витамина d, способ их получения, фармацевтическая композиция на их основе, способ лечения и профилактики патологических состояний
AU5782290A (en) 4,5-dihydro-6h-imidazo(4,5,1-ij)quinolin-6-one-6-oxime-0- sulfonic acid derivatives
JPS5775988A (en) Novel cephem compound and its preparation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003